// App-Quantinova.ai

POS09 : Effectiveness of a novel stent platform eluting sirolimus from a biodegradable polymer in percutaneous coronary intervention

Researchers

Presenter

  • Dominici M

Principal Investigators

  • Arrivi A

  • De Paolis M

  • Milici C

  • Bock C

  • Placanica A

  • Diletti R

  • Bazzucchi M

  • Boschetti E

Medical Centers

  • S. Maria University-Hospital, Terni, ID

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Cardiogenic shock

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

  • Clopidogrel bisulfate

  • Ticagrelor

  • Prasugrel

  • Rapacan

  • Aspirin

  • Albyl-E

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved